CDKN1B and neoplasm: In PI3K/AKT activated cancers, C-terminally phosphorylated p27 is overexpressed in the cytoplasm and nucleus, and binds proteins to drive tumor progression, which shifts p27 from a cyclin-dependent kinase inhibitor to an oncogene [45].